Who Paid My Doc Search
Menu
Product Program year 2024 Source: CMS Open Payments

LifeSPARC

Device Cardiology/Vascular Diseases

PDI 00814112020593

Open in the dashboard

General payments

$376,183

1,473 payments

Research payments

$0

0 payments

Through program year 2024, $376,183 in general payments and $0 in research payments were reported against LifeSPARC (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $47,279 59
2023 General $203,347 762
2022 General $125,557 652

Breakdown

Who paid General payments · program years 2022–2024
  1. LivaNova USA, Inc. $376,183 1,473 payments
Top recipients General payments · program year 2024
  1. Sandeep Patel Cardiovascular Disease · Lima, OH $12,358 26% · 8 payments
  2. Yasin Khan Pulmonary Disease · New Orleans, LA $10,868 23% · 7 payments
  3. I-Hui Chiang Interventional Cardiology · Mesa, AZ $7,089 15% · 5 payments
  4. Gabriel Hernandez Internal Medicine · Jackson, MS $5,344 11% · 4 payments
  5. Marquand Patton Interventional Cardiology · Miami, FL $4,838 10% · 2 payments

The top 5 of 29 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Interventional Cardiology Internal Medicine $16,901 36% · 6 practitioners
  2. Cardiovascular Disease Internal Medicine $12,736 27% · 4 practitioners
  3. Pulmonary Disease Internal Medicine $10,949 23% · 3 practitioners
  4. Internal Medicine $5,515 12% · 2 practitioners
  5. Thoracic Surgery (Cardiothoracic Vascular Surgery) $362 <1% · 4 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. Louisiana $15,523 33% · 3 recipients
  2. Ohio $12,358 26% · 1 recipient
  3. Arizona $7,089 15% · 1 recipient
  4. Florida $5,476 12% · 2 recipients
  5. Pennsylvania $4,866 10% · 2 recipients

The top 5 of 18 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

Records

1,473 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record